blatha, Author at NS Healthcare

Blatha

All articles by Blatha

Surgical precision with elastography imaging probe

|Paul Galluzzo is a chief researcher at The Technology Partnership (TTP). He studied engineering at the University of Cambridge. In 2003, he joined TTP, where he focuses on high-tech medical devices, such as ultrasound imaging, surgical devices, ophthalmics, medical optics and endoscopy.|An M-mode ultrasound scan showing the motion over time as ripples in the underlying ultrasound image. This motion is used to create the elastography image that is shown as a coloured overlay.|A comparison between elastography and conventional ultrasound images of a tissuemimicking material that contains a flaw. This is clearly visible when using elastograpy and nearly invisible without it.

Planning for the future: 3D mammography with DBT

|Vikram Butani

Prior to founding Kubtec Medical Imaging in 2005, Vikram Butani worked on research, development and the commercialisation of digital imaging. He holds multiple patents in X-ray and specimen tomosynthesis, and focuses on automation, improving medical outcomes and reducing costs.|The MOZART optical image shows an entire excised specimen (top, left); a 2D clip shows clusters of microcalciflcations (top, right); a tomography slice shows the largest group of microcalciflcations (bottom left); while bottom right shows a single microcalciflcation that is not obvious in the 2D view.|Kubtec’s MOZART, which uses 3D tomosynthesis for intraoperative specimen imaging, provides views of breasts in 1mm slices for analysis.

Say goodbye to surgery: addressing kidney tumours with CT scans

|Dr Mehrbod Javadi is an assistant professor of radiology and radiological science at Johns Hopkins Medicine, where he serves as director of nuclear medicine. The St George’s University’s medical school alumni is certified by the American Board of Nuclear Medicine and the American Board of Radiology.|Johns Hopkins’ research could lead the industry away from using surgery to characterise benign and malignant kidney tumours.|Renal cancer is one of the most common types in the UK; its symptoms include blood in urine and a persistent pain in the lower back or just below the ribs.

The future of the Middle East: SESAME

|SESAME during its construction. The centre officially opened in 2017, with the aim of fostering groundbreaking medical research and a culture of collaboration between member nations.

Embracing injectables and wearables

|The popularity of injectable biologics has risen due to their ability to treat a wide variety of conditions and their precision focus.|Dr Olivia Merkel is a professor at LMU Munich and an expert in drug delivery. Her research focuses on targeted siRNA and CRISPR-Cas9 delivery in cancer and inflammatory diseases.|For certain conditions, subcutaneous injections would eliminate the need for a specialist, reduce pain and allow patients to self-manage their illness.|Auto-injectors are easy to handle and have a very-defined dose. They come in two varieties: pre-filled syringes, or pens that hide the syringes.|With continual industry developments, delivering biologics may one day be as easy as taking a tablet.

Cold chain challenge

Philippe François heads Novartis’ supply chain function. He has over 25 years’ experience working for European and US multinationals, leading their operation functions in the healthcare and pharmaceutical sectors.||Products may be shipped in many ways, including liquid nitrogen and dry ice.|Documenting data is critical; temperature history should be recorded in order to ensure product quality and stability is maintained.

Through wind, snow and heat

|Savvas Koulouridas is a lawyer by profession and works as general manager at Fagron Hellas. He has worked as a consultant on pharmaceutical law, in GMP and GDP regulations, and pharmaceutical contracts.|It is important that companies follow products through the supply chain to the pharmacies and wholesalers to see if they are being properly stored.|The most important goal of pharmaceutical transportation is integrity; the products must be safe to use when they reach the user.

Name and number

|Mike Rose is vice-president of supply chain visibility at Johnson & Johnson. His duties include product identification and traceability, GS1 standards adoption and unique device identification.|A synchronised, global identification system will help to reduce medical errors.|New UDI legislation will optimise patient safety and care, and modernise post-market device surveillance.|Tom Jones is the director of end-to-end traceability and UDI programme director for Johnson & Johnson. He has worked in IT, business intelligence and supply chain at the company.|Dennis Hahn is the director of regulatory policy innovation for Johnson & Johnson medical devices. He oversees the implementation of global regulatory policies in Ethicon surgical device businesses.|

Excellence in cargo transport

|Andrea Gruber
As senior manager of special cargo, Andrea Gruber handles international standards and business processes for the air cargo supply chain. She leads the CEIV Pharma programme and is secretary to the TTTF.|Correctly transporting temperature-sensitive pharmaceuticals is essential to ensure they are fit for use upon reaching their destination.

Using chemicals to crack down on counterfeit drugs

|Michael Völlinger joined Grünenthal to implement and manage its global track and trace programme in 2017. Völlinger studied information engineering and management at the Karlsruher Institut für Technologie.|Chemical testing should be done at different points throughout the supply chain to maintain security.|Using chemical testing and track and trace methods enables companies to ensure greater drug safety.

NS Healthcare is using cookies

All articles by Blatha